Patients considered low risk for thrombosis or major bleeding should be observed only. Low-dose aspirin is recommended for patients without a history of thrombosis. For intermediate risk patients, symptom driven therapy for anaemia or constitutional symptoms. For high risk patients with a history of thrombosis, oral anticoagulants and cytoreductive drugs such as hydroxycarbamide are recommended, and the patient should be treated as in<unk><unk> .
Prefibrotic primary myelofibrosis
Acute panmyelosis with myelofibrosis
Accelerated phase chronic myelogenous leukemia
Chronic phase chronic myelogenous leukemia
AIDS-related lymphoma
Primary myelofibrosis
Refractory anemia with excess of blasts
Blastic phase chronic myelogenous leukemia